AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

10,000.00p
   
  • Change Today:
      31.00p
  • 52 Week High: 13,276.00p
  • 52 Week Low: 9,501.00p
  • Currency: UK Pounds
  • Shares Issued: 1,550.30m
  • Volume: 1,081,359
  • Market Cap: £155,030m
  • RiskGrade: 123
  • Beta: 0.87

Regulatory News

Director/PDMR Shareholding 20-Nov-2024 16:00 RNS
Tagrisso recommended for EU approval - LAURA 18-Nov-2024 07:00 RNS
Director/PDMR Shareholding 15-Nov-2024 14:00 RNS
Director/PDMR Shareholding 15-Nov-2024 10:00 RNS
Director/PDMR Shareholding 13-Nov-2024 16:00 RNS
AstraZeneca invests $3.5 billion in US 12-Nov-2024 07:10 RNS
KOMET Phase III trial met primary endpoint 12-Nov-2024 07:05 RNS
9M and Q3 2024 Results 12-Nov-2024 07:00 RNS
Dato-DXd new BLA submitted, NSQ BLA withdrawn 12-Nov-2024 07:00 RNS
Tezspire nasal polyps trial met primary endpoints 08-Nov-2024 07:00 RNS
AZN share price movement 05-Nov-2024 16:49 RNS
Total Voting Rights 01-Nov-2024 15:00 RNS
AZN China President under investigation 30-Oct-2024 13:00 RNS
Wainzua recommended for approval in the EU 21-Oct-2024 07:00 RNS
AstraZeneca licenses lipid lowering Lp(a) asset 07-Oct-2024 09:30 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 10,000.00p
Change Today 31.00p
% Change 0.31 %
52 Week High 13,276.00p
52 Week Low 9,501.00p
Volume 1,081,359
Shares Issued 1,550.30m
Market Cap £155,030m
Beta 0.87
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
87.66% below the market average87.66% below the market average87.66% below the market average87.66% below the market average87.66% below the market average
88% below the sector average88% below the sector average88% below the sector average88% below the sector average88% below the sector average
Price Trend
27.11% below the market average27.11% below the market average27.11% below the market average27.11% below the market average27.11% below the market average
34.69% above the sector average34.69% above the sector average34.69% above the sector average34.69% above the sector average34.69% above the sector average
Income
78.05% below the market average78.05% below the market average78.05% below the market average78.05% below the market average78.05% below the market average
42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average
Growth
88.44% above the market average88.44% above the market average88.44% above the market average88.44% above the market average88.44% above the market average
94.12% above the sector average94.12% above the sector average94.12% above the sector average94.12% above the sector average94.12% above the sector average

What The Brokers Say

Strong Buy 9
Buy 15
Neutral 5
Sell 0
Strong Sell 1
Total 30
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 08-Aug-24 22-Feb-24
Paid 09-Sep-24 25-Mar-24
Amount 100.00¢ 197.00¢

Trades for 21-Nov-2024

Time Volume / Share Price
13:04 99 @ 10,000.00p
13:04 62 @ 10,002.00p
13:04 72 @ 10,002.00p
13:04 106 @ 10,002.00p
13:04 43 @ 10,004.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page